HQ Function

Served as the primary center for corporate operations, research and development oversight, and administrative functions for the oncology-focused biopharmaceutical company prior to its bankruptcy and asset sales in 2023.

Notable Features:

Located in a modern business park, the facility was designed to support biotech research coordination and administrative functions.

Work Culture:

Historically, the work culture was driven by a mission to develop impactful cancer therapies, emphasizing scientific innovation, collaboration, and a patient-centric approach. This reflects the period before the company's Chapter 11 filing and subsequent operational wind-down.

HQ Significance:

The Boulder headquarters was central to Clovis Oncology's efforts in developing and commercializing its oncology pipeline, most notably Rubraca, and managing its global clinical trials and operations before its acquisition.

Values Reflected in HQ: The operations at this HQ historically reflected values such as scientific rigor, commitment to patients, and innovation in oncology. Post-bankruptcy and asset sales, the site's role as Clovis Oncology's active HQ ceased.

Location:

Prior to its bankruptcy and asset sales in 2023, Clovis Oncology had a global presence focused on the development and commercialization of its cancer therapies. This included conducting clinical trials in North America, Europe, and other regions. Commercial operations for its flagship product, Rubraca, were established in the United States and key European markets. Its global functions supported drug development, regulatory submissions, and market access for its oncology portfolio, all of which have ceased under the Clovis Oncology name due to the company's restructuring.

Street Address:

5500 Flatiron Parkway, Suite 100

City:

Boulder

State/Province:

Colorado

Country:

USA